Article
Exosomes derived from mesenchymal stem cells improved core symptoms of genetically modified mice model of autism Shank3B
2020-07-23
Abstract excerpt
<title>Abstract</title> <p>Background: Partial or an entire deletion of <italic>SHANK3</italic> are considered as major drivers in the Phelan McDermid syndrome, in which 75% of patients are diagnosed with autism spectrum disorder (ASD). During the recent years, there was an increasing interest in stem cell therapy in ASD, and specifically, mesenchymal stem cells (MSC). Moreover, it has been suggested that the the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- db70ccc2-08fb-5304-b637-bb21984589d2
- DOI
- 10.21203/rs.3.rs-17171/v3
